These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14456758)

  • 1. [Dynamographic research on the control of cerebral circulation volume by the "monoamine oxidase inhibitor" niamide].
    KLEIN K
    Med Klin; 1962 Jun; 57():1089-92. PubMed ID: 14456758
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative cardiovascular effects of the inhibitors of monoamine oxidase. Pharmacological effects. Action on cardiac dynamics and metabolism].
    CAHN J; HEROLD MM
    Chemotherapia (Basel); 1962; 4():262-96. PubMed ID: 13875575
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diminution of the fertility of the rat subjected to chronic treatment with Niamide].
    TUCHMANN-DUPLESSIS H; MERCIER-PAROT L
    C R Hebd Seances Acad Sci; 1961 Jul; 253():712-4. PubMed ID: 13922977
    [No Abstract]   [Full Text] [Related]  

  • 4. Attenuation of cardiovascular responses to exercise as a possible basis for effectiveness of monoamine oxidase inhibitors in angina pectoris.
    GOLDBERG LI; HORWITZ D; SJOERDSMA A
    J Pharmacol Exp Ther; 1962 Jul; 137():39-46. PubMed ID: 13899703
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of monoamine oxidase in the brain of man after therapy with monoamine oxidase inhibitors].
    BERNHEIMER H; BIRKMAYER W; HORNYKIEWICZ O
    Wien Klin Wochenschr; 1962 Aug; 74():558-9. PubMed ID: 13868185
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation of the cerebral biochemical and functional effects of monoamine oxidase inhibitor antidepressants.
    MARRAZZI AS; HART ER; RODRIGUEZ JM; GLUCKMAN MI; HOROVITZ ZP
    Recent Adv Biol Psychiatry; 1961; 4():266-75. PubMed ID: 14470182
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the circulatory action of Niamid in atopic diseases].
    STORCK H; HEIM E; KONZELMANN M
    Chemotherapia (Basel); 1962; 4():196-202. PubMed ID: 13917507
    [No Abstract]   [Full Text] [Related]  

  • 8. Potentiation of the cardiovascular effects of some catecholamines by a monoamine oxidase inhibitor.
    Cuthbert MF; Vere DW
    Br J Pharmacol; 1971 Oct; 43(2):471P-472P. PubMed ID: 5158241
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of some anti-depressive agents on the carbohydrate metabolism and monoamine oxidase activity in the brain tissue].
    KAIZAWA S
    Keio J Med; 1962 Mar; 39():89-101. PubMed ID: 14453172
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the pharmacology of Phelazine-a monoamine oxidase inhibitor].
    LIBERMAN SS
    Farmakol Toksikol; 1962; 25():175-9. PubMed ID: 14465043
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the central effect of neurohormones. I. Local effect of adrenalin, noradrenalin and monoamine oxidase inhibitors on the excitability and bioelectric activity of cardiovascular centers of the hypothalamus and the reticular formation of the brain stem].
    TRZEBSKI A
    Acta Physiol Pol; 1961; 12():793-811. PubMed ID: 13922736
    [No Abstract]   [Full Text] [Related]  

  • 12. [Introduction to a pharmacological study of the inhibitors of monoamine oxidase].
    DOLIVO M
    Chemotherapia (Basel); 1962; 4():212-8. PubMed ID: 13887036
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for a possible role of endogenous catecholamines in the vascular changes produced in rat intestine by x-rays.
    WILLOUGHBY DA
    J Pathol Bacteriol; 1962 Apr; 83():389-97. PubMed ID: 14007284
    [No Abstract]   [Full Text] [Related]  

  • 14. [ANTIDEPRESSIVE TREATMENT WITH MONOAMINE OXIDASE (MAO) INHIBITORS. I. SIDE-EFFECTS AND RISKS OF POTENTIATION].
    HOLMBERG G; SJOEQVIST F
    Sven Lakartidn; 1964 Dec; 61():3762-93. PubMed ID: 14276462
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD; Mendels J; Frazer A
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of nicotine on cerebral blood circulation and venous pressure].
    SOLTI F; PETER A; OLAH I; ISKUM M; REV J; HERMANN R; REFI Z
    Kiserl Orvostud; 1962 Jun; 14():269-72. PubMed ID: 13915063
    [No Abstract]   [Full Text] [Related]  

  • 17. [Activity of mouse cerebral monoamine oxidase as a function of the means of administration of a MAO inhibitor].
    Levy J; Michel-Ber E
    Therapie; 1966; 21(3):633-44. PubMed ID: 5942129
    [No Abstract]   [Full Text] [Related]  

  • 18. [Research on the action of vasoactive drugs on cerebral circulation in patients suffering from apoplectic strokes. III. Action of papaverine].
    NUTI A; SCIAGRA A
    Riv Crit Clin Med; 1959 Apr; 59():317-23. PubMed ID: 14427946
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative research on 6-methyl-2-heptylhydrazine and other monoamine oxidase inhibitors].
    HAAS H; APPEL W
    Arzneimittelforschung; 1962 Apr; 12():352-9. PubMed ID: 13903350
    [No Abstract]   [Full Text] [Related]  

  • 20. Further studies with tranylcypromine (monamine oxidase inhibitor) and its interaction with reserpine in rat brain.
    GREEN H; ERICKSON RW
    Arch Int Pharmacodyn Ther; 1962 Feb; 135():407-25. PubMed ID: 13901404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.